Both drugs were added to FDA's drug shortage list in 2022 due to surging demand, which triggered statutory provisions permitting 503A pharmacies and 503B outsourcing facilities to compound those products
Before prescribing a GLP-1 medication, a provider may need to review the patients overall health, current medications, previous treatment efforts, medical history, treatment goals, and potential risks
2 Notwithstanding, there is a current debate whether the use of GLP-1RA in Danish T2D patients is too high and may happen too early in the therapy line
It is available both as an injection and also as an orally administered offering
doi: 10.1038/clpt.1994.85 Novakova K., Kummer O., Bouitbir J., Stoffel S.D., Hoerler-Koerner U., Bodmer M., Roberts P., Urwyler A., Ehrsam R., Krhenbhl S
Reddy's, Lupin all in